We are honored to host this upcoming MedTalk, especially as we proudly welcome Ypsomed as our newest Partner! Ypsomed is a leading developer of advanced self-injection and infusion systems, enabling millions of patients to manage chronic conditions from the comfort of their own homes. The Swiss-based company engineers a comprehensive portfolio of pre-filled pens, autoinjectors, and wearable patch injectors, combining precision manufacturing with smart, connected digital solutions for therapy management. In this MedTalk, Marcel Gort — who previously studied and completed his Dr. sc. at ETH — will walk us through the innovation journey at Ypsomed: from identifying an unmet patient need to early concepts, functional prototypes, and the key decisions that shape the final product. Using a real example, he will show how multidisciplinary teams across mechanics, simulation, testing, risk management, and user research collaborate to bring a self-care drug delivery device to life. Beyond the technical aspects, the talk will also explore what it means to develop devices for self-care, with a focus on safety, usability, and patient behaviour. Whether you are interested in MedTech product development, biomedical engineering, or human-centered design — this is your chance to see how a patient need becomes a product used by millions.
